[go: up one dir, main page]

ES2043535A1 - Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES2043535A1
ES2043535A1 ES9200552A ES9200552A ES2043535A1 ES 2043535 A1 ES2043535 A1 ES 2043535A1 ES 9200552 A ES9200552 A ES 9200552A ES 9200552 A ES9200552 A ES 9200552A ES 2043535 A1 ES2043535 A1 ES 2043535A1
Authority
ES
Spain
Prior art keywords
methyl
carbazol
ona
imidazol
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9200552A
Other languages
Spanish (es)
Other versions
ES2043535B1 (en
Inventor
Clotet Juan Huguet
Ges Jose Maria Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Pharma Iberia SL
Original Assignee
Vita Invest SA
Quimica Sintetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA, Quimica Sintetica SA filed Critical Vita Invest SA
Priority to ES09200552A priority Critical patent/ES2043535B1/en
Priority to SK169-93A priority patent/SK278786B6/en
Priority to GR930100094A priority patent/GR930100094A/en
Priority to CZ93396A priority patent/CZ281753B6/en
Priority to EG14493A priority patent/EG20262A/en
Priority to IS3985A priority patent/IS1783B/en
Priority to PT101216A priority patent/PT101216B/en
Priority to AR93324474A priority patent/AR248019A1/en
Priority to NO930887A priority patent/NO300973B1/en
Priority to KR1019930003609A priority patent/KR100277414B1/en
Priority to PL93298037A priority patent/PL170751B1/en
Priority to HU9300718A priority patent/HU210775B/en
Priority to FI931104A priority patent/FI105098B/en
Priority to RU93004833/04A priority patent/RU2109741C1/en
Priority to AT0048793A priority patent/AT402730B/en
Publication of ES2043535A1 publication Critical patent/ES2043535A1/en
Application granted granted Critical
Publication of ES2043535B1 publication Critical patent/ES2043535B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,2,3,9-TETRAHIDRO-9-METIL-3- [(2-METIL-1H-IMIDAZOL-1-IL) METIL] -4H-CARBAZOL-4-ONA DE FORMULA I POR CICLACION DEL COMPUESTO DE FORMULA II BAJO CONDICIONES DE LA ACILACION DE FRIEDELCRAFTS, MEDIANTE ACTIVACION DEL GRUPO CARBOXILO, CON CATALISIS ACIDA, EN UN MEDIO DISOLVENTE ADECUADO Y AISLAR EL PRODUCTO DESEADO POR LOS METODOS CONVENCIONALES. PRESENTA PROPIEDADES COMO ANTIEMETICO EN QUIMIOTERAPIA, ASI COMO EN EL TRATAMIENTO DE LA JAQUECA, ESQUIZOFRENIA, ANSIEDAD, OBESIDAD Y MANIA.PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- [(2-METHYL-1H-IMIDAZOL-1-IL) METHYL] -4H-CARBAZOL-4-ONA OF FORMULA I BY CYCLING OF THE COMPOUND OF FORMULA II UNDER THE CONDITIONS OF THE ACILATION OF FRIEDELCRAFTS, THROUGH ACTIVATION OF THE CARBOXYL GROUP, WITH ACID CATALYSIS, IN AN ADEQUATE SOLVENT MEDIUM AND ISOLATE THE DESIRED PRODUCT BY CONVENTIONAL METHODS. PRESENTS PROPERTIES AS AN ANTIEMETIC IN CHEMOTHERAPY, AS WELL AS IN THE TREATMENT OF JAQUECA, SCHIZOPHRENIA, ANXIETY, OBESITY AND MANIA.

ES09200552A 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA. Expired - Fee Related ES2043535B1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
SK169-93A SK278786B6 (en) 1992-03-13 1993-03-08 METHOD OF PRODUCTION 1,2,3,9-TETRAHYDRO-9-METYL-3 - [(2-MET
GR930100094A GR930100094A (en) 1992-03-13 1993-03-09 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1h-imidazol-1-yl)methylÜ-4ii-carbazol-4-one.
EG14493A EG20262A (en) 1992-03-13 1993-03-10 A process for preparing 1,2,3,9- tetrahydro -9- methyl -3-( 2- metyl -1H-imidazol -1- YL) methyl) -4H- carbazol -4- one
CZ93396A CZ281753B6 (en) 1992-03-13 1993-03-10 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-£(2-methyl-1h-imidazol-1-yl)-methyl| -4h-carbazol-4-one
KR1019930003609A KR100277414B1 (en) 1992-03-13 1993-03-11 Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
AR93324474A AR248019A1 (en) 1992-03-13 1993-03-11 Procedure for obtaining 1, 2, 3, 9-tetra hydro-9-methyl-3- ((2-methyl-1h-imidazole-1-il)methyl)-4 h-carbazole-4-on a.
NO930887A NO300973B1 (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3- [2- (2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
IS3985A IS1783B (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
PT101216A PT101216B (en) 1992-03-13 1993-03-11 PROCESS FOR THE PREPARATION OF 1,2,3,9-TETRAHYDRO-9-METHYL-3 - {(2-METHYL-1H-IMIDAZOL-1-YL) METHYL} -4H-CARBAZOLE-4-ONES
HU9300718A HU210775B (en) 1992-03-13 1993-03-12 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl-4h-carbazol-4-one
FI931104A FI105098B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
RU93004833/04A RU2109741C1 (en) 1992-03-13 1993-03-12 Method of preparing 1,2,3,9-tetrahydro-9-methyl-3-(2- methyl-1h-imidazol-1-yl)-methyl-4h-carbazol-4-one of formula i
AT0048793A AT402730B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9- methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol- 4-one
PL93298037A PL170751B1 (en) 1992-03-13 1993-03-12 4H-carbazolone-4 PL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Publications (2)

Publication Number Publication Date
ES2043535A1 true ES2043535A1 (en) 1993-12-16
ES2043535B1 ES2043535B1 (en) 1994-08-01

Family

ID=8276385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09200552A Expired - Fee Related ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Country Status (15)

Country Link
KR (1) KR100277414B1 (en)
AR (1) AR248019A1 (en)
AT (1) AT402730B (en)
CZ (1) CZ281753B6 (en)
EG (1) EG20262A (en)
ES (1) ES2043535B1 (en)
FI (1) FI105098B (en)
GR (1) GR930100094A (en)
HU (1) HU210775B (en)
IS (1) IS1783B (en)
NO (1) NO300973B1 (en)
PL (1) PL170751B1 (en)
PT (1) PT101216B (en)
RU (1) RU2109741C1 (en)
SK (1) SK278786B6 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100368895B1 (en) * 2000-03-30 2003-01-24 하나제약 주식회사 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
RU2207340C2 (en) * 2001-08-10 2003-06-27 Ципла Лтд. Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801247A1 (en) * 1984-01-25 1987-12-16 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
GB2192885A (en) * 1986-07-23 1988-01-27 Glaxo Group Ltd Heterocyclic compounds
US4725615A (en) * 1985-07-24 1988-02-16 Glaxo Group Limited Carbazole derivatives and their use as 5HT-induced antagonists
ES2000936A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
ES2000935A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801247A1 (en) * 1984-01-25 1987-12-16 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
US4725615A (en) * 1985-07-24 1988-02-16 Glaxo Group Limited Carbazole derivatives and their use as 5HT-induced antagonists
ES2000936A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
ES2000935A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
GB2192885A (en) * 1986-07-23 1988-01-27 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
SK16993A3 (en) 1993-11-10
HU9300718D0 (en) 1993-05-28
PT101216B (en) 1999-10-29
HUT64537A (en) 1994-01-28
NO300973B1 (en) 1997-08-25
FI931104L (en) 1993-09-14
KR100277414B1 (en) 2001-01-15
KR930019665A (en) 1993-10-18
PL298037A1 (en) 1993-12-27
EG20262A (en) 1998-05-31
PL170751B1 (en) 1997-01-31
AT402730B (en) 1997-08-25
ES2043535B1 (en) 1994-08-01
IS1783B (en) 2001-10-22
CZ281753B6 (en) 1997-01-15
CZ39693A3 (en) 1994-01-19
GR930100094A (en) 1993-11-30
ATA48793A (en) 1996-12-15
NO930887D0 (en) 1993-03-11
NO930887L (en) 1993-09-14
FI931104A0 (en) 1993-03-12
PT101216A (en) 1994-03-31
SK278786B6 (en) 1998-02-04
AR248019A1 (en) 1995-05-31
FI105098B (en) 2000-06-15
HU210775B (en) 1995-07-28
IS3985A (en) 1993-09-14
RU2109741C1 (en) 1998-04-27

Similar Documents

Publication Publication Date Title
ES2077575T3 (en) PROCEDURE FOR THE PREPARATION OF MODIFIED POLYPHENYLENE-ETER OR RELATED POLYMERS AND THEIR USE IN MODIFIED, HIGH TEMPERATURE RIGID POLYMERS OF VINYL SUBSTITUTED AROMATIC COMPOUNDS.
ES2070253T3 (en) SUBSTITUTED CYCLOHEXANOLS USEFUL AS AGENTS FOR THE CENTRAL NERVOUS SYSTEM.
ES2140510T3 (en) SYSTEM TO CONTROL THE COLOR OF ONE OR MULTIPLE POLYMERS IN COMPOSITION USING COLOR MEASUREMENTS DURING THEIR TREATMENT.
KR940005777A (en) Gelled polymer solution and preparation method thereof
AR001183A1 (en) Complex compounds and method for their preparation components for catalyst supports thus supported process for preparing said components process for preparing said complexes and process for preparing said supported catalysts and application adducts in the preparation of said components and polymerization processes with application of said catalysts
AR006463A1 (en) COMPOSITION OF MAGNESIUM, TITANIUM, HALOGEN AND ESTER OF CARBOXYLIC ACID; PROCESS FOR ITS PREPARATION, USE OF THE SAME AS A CATALYST, CATALYST COMPONENT OR IN THE PREPARATION OF A CATALYST, PRODUCT OR INTERMEDIATE PRODUCT OF POLYMERIZATION CATALYZED BY THE COMPOSITION OR PREPARED BY
SV1995000062A (en) DERIVATIVES OF CICLOALCANO-INDOL Y - AZAINDOL REF. Le A 30 699
ECSP045209A (en) NEW ESTERES OF FLUORENE ACIDS - CARBOXILICS, PROCEDURES FOR THEIR PREPARATION AS WELL AS ITS USE IN QUALITY OF MEDICINES
ES2043535A1 (en) Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding)
ZA911815B (en) Fluorobenzenesulfonamides
ES2057341T3 (en) CYCLOHEXENOS SUBSTITUTED AS AGENTS FOR THE CENTRAL NERVOUS SYSTEM.
ES2128314T3 (en) NEW POWERFUL TERMINAL DIFFERENTIATION INDUCTORS AND METHOD OF USE THEREOF.
AR007970A1 (en) SUBSTITUTED PYRROLES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
AR013844A1 (en) COMPOUNDS DERIVED FROM 3-OXO-PIRIDO [1,2-A] BENCIMIDAZOL-4-CARBOXAMIDE REPLACED IN POSITION 5 WITH RENT CONTAINING HETEROATOMO, - AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
ES2156319T3 (en) DERIVATIVES OF 10,11-DIHIDRO-10-OXO-5H-DIBENZ / B, F / AZEPIN-5-CARBOXAMIDA.
RU99127483A (en) METHOD OF BALMING ANATOMIC PREPARATIONS BY SILOXANE COMPOSITIONS
ES2128622T3 (en) PROCEDURE FOR THE OBTAINING OF MONO- OR DICARBOXYLIC ACIDS FROM ALDEHYDES OF THEIR TOTAL ACETALS OR OF THEIR SEMI-ACETALS, AS WELL AS OF THEIR MIXTURES.
KR900000365A (en) Condensed diazepinone, preparation method thereof and pharmaceutical composition containing same
ES2111297T3 (en) NEW ESTERS OF 2-AMINO-7- (1,3-DIHIDROXI-2-PROPOXIMETIL) PURINE CARBOXYLIC ACIDS, THEIR PREPARATION AS WELL AS THEIR USE.
ES2039211T3 (en) NEW N-GLYCOSILAMIDODERIVES, PROCEDURES FOR THEIR OBTAINING AND USE AS MEDICINES.
IT1113373B (en) DERIVATIVES OF 1,5-DIMETYL BICYCLE (3.2.1.) - OCTANO, PREPARATION OF THESE COMPOUNDS AND THEIR USE AS COMPOUNDS FOR PERFUMES
EP1233075A3 (en) BDNF polymorphism and association with bipolar disorder
ES8603800A1 (en) 4-Hydroxy-alpha-ethyl benzhydroles, process for their preparation and medicines containing these compounds.
ES2124280T3 (en) O-PHENYLENDIAMINS CONTAINING FLUORALKYL (ENO) GROUPS AND THEIR USE AS INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF BENZIMIDAZOLES.
ES8302670A1 (en) 2-hydroxymethyl-quinoxaline-1,4-dioxide derivatives,a process for preparing same and compositions containing same

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19980113

PC2A Transfer of patent
GC2A Exploitation certificate registered application with search report

Effective date: 20030305

PC2A Transfer of patent
PC2A Transfer of patent
PC2A Transfer of patent

Owner name: WARNER CHILCOTT IBERIA, S.L.

Effective date: 20120411

FD2A Announcement of lapse in spain

Effective date: 20141120